FDA Approves Genentech’s Enspryng, a First-in-Class IL-6R Inhibitor, as the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Chugai Pharmaceutical Ltd Unsponsored ADR (AMEX: CHGCY) | Delayed: 21.20 +0.68 (3.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.52 | 52 Week High | $74.63 | |||
| Open | $20.26 | 52 Week Low | $56.80 | |||
| Day High | $21.46 | P/E | N/A | |||
| Day Low | $20.26 | EPS | $0.00 | |||
| Volume | 495,515 | |||||
| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 59.70 +0.59 (1.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.11 | 52 Week High | $35.13 | |||
| Open | $58.65 | 52 Week Low | $28.10 | |||
| Day High | $59.83 | P/E | N/A | |||
| Day Low | $58.41 | EPS | $0.00 | |||
| Volume | 911,768 | |||||
